Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| End Stage Liver Disease | 3 | 2023 | 73 | 1.880 |
Why?
|
| Liver Transplantation | 5 | 2023 | 847 | 1.870 |
Why?
|
| Tissue and Organ Procurement | 2 | 2023 | 248 | 1.470 |
Why?
|
| Kidney Transplantation | 2 | 2023 | 585 | 1.170 |
Why?
|
| Transplant Recipients | 2 | 2024 | 148 | 1.050 |
Why?
|
| Cytomegalovirus Infections | 1 | 2024 | 187 | 0.810 |
Why?
|
| Living Donors | 5 | 2023 | 319 | 0.800 |
Why?
|
| Alzheimer Disease | 3 | 2019 | 513 | 0.320 |
Why?
|
| Retrospective Studies | 6 | 2024 | 12978 | 0.320 |
Why?
|
| Registries | 2 | 2024 | 1810 | 0.270 |
Why?
|
| Cytomegalovirus | 1 | 2024 | 144 | 0.220 |
Why?
|
| Waiting Lists | 1 | 2023 | 228 | 0.200 |
Why?
|
| Graft Survival | 1 | 2023 | 504 | 0.190 |
Why?
|
| Cholestasis | 1 | 2023 | 228 | 0.180 |
Why?
|
| tau Proteins | 1 | 2019 | 78 | 0.160 |
Why?
|
| United States | 3 | 2023 | 12555 | 0.160 |
Why?
|
| Severity of Illness Index | 2 | 2023 | 2674 | 0.160 |
Why?
|
| Genotyping Techniques | 1 | 2018 | 75 | 0.160 |
Why?
|
| Immunity | 1 | 2019 | 129 | 0.160 |
Why?
|
| Quality Control | 1 | 2018 | 159 | 0.160 |
Why?
|
| Whole Genome Sequencing | 1 | 2018 | 113 | 0.160 |
Why?
|
| Phospholipase C gamma | 1 | 2017 | 25 | 0.150 |
Why?
|
| Genetic Loci | 1 | 2019 | 281 | 0.150 |
Why?
|
| Humans | 11 | 2024 | 118972 | 0.150 |
Why?
|
| Amyloid beta-Peptides | 1 | 2019 | 200 | 0.140 |
Why?
|
| Receptors, Immunologic | 1 | 2017 | 209 | 0.140 |
Why?
|
| Microglia | 1 | 2017 | 221 | 0.130 |
Why?
|
| Lipids | 1 | 2019 | 607 | 0.130 |
Why?
|
| Membrane Glycoproteins | 1 | 2017 | 446 | 0.130 |
Why?
|
| Prognosis | 1 | 2023 | 3443 | 0.130 |
Why?
|
| Genome-Wide Association Study | 2 | 2019 | 1323 | 0.130 |
Why?
|
| Liver | 1 | 2023 | 1816 | 0.130 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2017 | 394 | 0.120 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2014 | 152 | 0.120 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2019 | 2275 | 0.110 |
Why?
|
| Treatment Outcome | 2 | 2023 | 9342 | 0.110 |
Why?
|
| Sequence Analysis, DNA | 1 | 2014 | 755 | 0.100 |
Why?
|
| Adult | 2 | 2024 | 31512 | 0.100 |
Why?
|
| Immunity, Innate | 1 | 2017 | 745 | 0.100 |
Why?
|
| Promoter Regions, Genetic | 1 | 2014 | 1158 | 0.090 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2017 | 2062 | 0.090 |
Why?
|
| Case-Control Studies | 3 | 2022 | 3171 | 0.080 |
Why?
|
| DNA | 1 | 2014 | 1388 | 0.080 |
Why?
|
| Genotype | 2 | 2018 | 1882 | 0.050 |
Why?
|
| Constriction, Pathologic | 1 | 2023 | 203 | 0.050 |
Why?
|
| Catheterization | 1 | 2023 | 163 | 0.050 |
Why?
|
| Sodium | 1 | 2022 | 200 | 0.050 |
Why?
|
| Protein Interaction Maps | 1 | 2017 | 36 | 0.040 |
Why?
|
| Haplotypes | 1 | 2019 | 473 | 0.040 |
Why?
|
| Linkage Disequilibrium | 1 | 2017 | 273 | 0.040 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2017 | 372 | 0.040 |
Why?
|
| Genetic Testing | 1 | 2019 | 389 | 0.040 |
Why?
|
| Exome | 1 | 2017 | 220 | 0.030 |
Why?
|
| Gene Frequency | 1 | 2017 | 513 | 0.030 |
Why?
|
| Lipid Metabolism | 1 | 2019 | 477 | 0.030 |
Why?
|
| Programming Languages | 1 | 2014 | 24 | 0.030 |
Why?
|
| Polymorphism, Genetic | 1 | 2018 | 642 | 0.030 |
Why?
|
| Odds Ratio | 1 | 2017 | 996 | 0.030 |
Why?
|
| Amino Acid Sequence | 1 | 2017 | 2071 | 0.030 |
Why?
|
| Algorithms | 1 | 2018 | 1541 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2017 | 1597 | 0.020 |
Why?
|
| Male | 3 | 2022 | 57801 | 0.020 |
Why?
|
| Female | 3 | 2022 | 61564 | 0.020 |
Why?
|
| Aged | 1 | 2019 | 19657 | 0.010 |
Why?
|